SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 235 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $125 | 0.0% | 4,148 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $125 | -24.7% | 4,148 | -9.7% | 0.00% | 0.0% |
Q1 2023 | $166 | +6.4% | 4,594 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $156 | -99.9% | 4,594 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $156,000 | +17.3% | 4,594 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $133,000 | -58.7% | 4,594 | -66.2% | 0.00% | -50.0% |
Q4 2019 | $322,000 | -13.9% | 13,592 | 0.0% | 0.00% | -33.3% |
Q3 2019 | $374,000 | -49.8% | 13,592 | -39.6% | 0.00% | -50.0% |
Q2 2019 | $745,000 | -5.6% | 22,509 | 0.0% | 0.01% | 0.0% |
Q1 2019 | $789,000 | +68.2% | 22,509 | +141.9% | 0.01% | +50.0% |
Q3 2018 | $469,000 | -15.8% | 9,306 | 0.0% | 0.00% | -20.0% |
Q2 2018 | $557,000 | -57.1% | 9,306 | -67.2% | 0.01% | -58.3% |
Q1 2018 | $1,299,000 | +15.0% | 28,358 | 0.0% | 0.01% | +20.0% |
Q4 2017 | $1,130,000 | -0.4% | 28,358 | 0.0% | 0.01% | 0.0% |
Q3 2017 | $1,134,000 | -7.2% | 28,358 | 0.0% | 0.01% | -16.7% |
Q2 2017 | $1,222,000 | – | 28,358 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
S&T BANK/PA | 215,578 | $5,943 | 1.15% |
Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |